BridgeMD
New treatment option for Graves Disease
Official title Course for Brain Fatigue After Graves' Disease Controlled Study
ClinicalTrials.gov ID: NCT06134219
What this study is testing
- What it's testing
- BACKGROUND. Mental fatigue (MF) is common in the most common form of hyperthyroidism, Graves' disease (GD).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 72
You may be able to join if
- 18-72 years old
- 15-72 months since first Graves' diagnosis
- high free thyroxin and thyroid antibodies (TRAb) at diagnosis
- euthyroid the last 6 months normal thyroid hormone levels at inclusion
- symptoms on MF in connection to Graves diagnosis
You likely can't join if
- other diseases or situations that may be associated with mental fatigue (such as other active inflammatory disease, neurological disease)
- pregnancy
- lactation
- assessment that the patient cannot follow the study protocol.
See the full eligibility criteria
- 18-72 years old
- 15-72 months since first Graves' diagnosis
- high free thyroxin and thyroid antibodies (TRAb) at diagnosis
- euthyroid the last 6 months normal thyroid hormone levels at inclusion
- symptoms on MF in connection to Graves diagnosis
- MF-scale ≥10.5 points
- other diseases or situations that may be associated with mental fatigue (such as other active inflammatory disease, neurological disease)
- pregnancy
- lactation
- assessment that the patient cannot follow the study protocol.
The study team makes the final eligibility decision.
Where it's taking place
- Gothenburg, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 72 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Gothenburg, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.